Why does null hypothesis testing matter for TTC-based infarct quantification?

Null hypothesis testing ensures that observed differences in infarct size after MCAO and TTC staining are statistically significant, supporting robust target validation and reducing false positives in early discovery.

How does independent variable isolation fit the MCAO surgical workflow?

Isolating variables such as occlusion duration or compound administration allows teams to attribute changes in infarct size directly to specific interventions, strengthening mechanistic insights and discovery pipeline decisions.

What do quantitative TTC measurements enable in preclinical stroke studies?

Quantitative TTC measurements provide objective endpoints for comparing treatment efficacy, facilitating data-driven advancement of neuroprotective candidates and supporting cross-study reproducibility.

Why are replication requirements critical for cross-functional MCAO studies?

Replication ensures that infarct size reductions or other outcomes are consistent across experiments and teams, enabling reliable cross-functional collaboration and portfolio-level decision making.

What statistical analysis capabilities are required before implementing MCAO efficacy screens?

Teams must establish statistical methods for analyzing infarct size distributions and treatment effects, ensuring that efficacy screens yield actionable, reproducible data for R&D progression.

עכבר דגם ספיגה התיכון עורק מוחי

80.3K צפיות

צוטט 168 פעמים

09:43 דק'

13 בפברואר 2011

10.3791/2761-v

13 בפברואר 2011

80.3K צפיות

Terrance Chiang¹ , Robert O. Messing¹ , Wen-Hai Chou¹^,²

¹Department of Neurology, Ernest Gallo Clinic and Research Center, University of California, San Francisco, ²Department of Biological Sciences, Kent State University

אנו מדגימים את הוידאו שיטה לייצור באמצע חסימה בעורק המוח בעכברים בוגרים באמצעות monofilament intraluminal. כמו כן, אנו מראים כיצד להעריך את מידת אוטם מוחי על ידי מכתים 2,3,5-triphenyltetrazolium כלוריד (TTC).